FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for the lymphocyte protection against apoptosis. That is ensured by adding 1,4-dithioerythritol and ascorbic acid in the final concentration of 3.0 mmole and 0.1 mmole respectively to an incubation medium containing lymphocytes.
EFFECT: invention enables protecting lymphocytes against apoptosis by the combined use of ascorbate and SH group protector, 1,4-dithioerythritol.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING EFFECTIVENESS OF LYMPHOCYTE PROTECTION AGAINST APOPTOSIS | 2014 |
|
RU2568886C1 |
| METHOD FOR PREDICTION OF EARLY STAGE OF APOPTOSIS | 2013 |
|
RU2540500C2 |
| METHOD FOR PREDICTION OF EFFECTIVENESS OF LYMPHOCYTE PROTECTION AGAINST PEROXIDATION | 2013 |
|
RU2525183C1 |
| DIAGNOSTIC TECHNIQUE FOR LYMPHOCYTE APOPTOSIS | 2013 |
|
RU2545900C2 |
| METHOD FOR ESTIMATING EFFECTIVENESS OF ANTIOXIDANT ACTIVITY STIMULATION | 2013 |
|
RU2516925C1 |
| METHOD FOR SIMULATING LYMPHOCYTE PEROXIDATION | 2013 |
|
RU2541771C2 |
| METHOD OF DETERMINING GLUTATHIONE IN BIOLOGICALLY ACTIVE ADDITIVES USING CATHODE VOLTAMMETRY TECHNIQUE | 2010 |
|
RU2441225C1 |
| ANTIOXIDANT, STRESS AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT SODIUM COMENATE | 2012 |
|
RU2506078C1 |
| ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT POTASSIUM COMENATE | 2012 |
|
RU2514632C1 |
| METHOD OF GENETIC TYPING OF POLYMORPHISM rs2551715 OF HUMAN GLUTATHIONE REDUCTASE GENE | 2013 |
|
RU2549688C1 |
